Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism

BACKGROUND: Testosterone replacement therapy (TRT) is one of the main lines of treatment for men with hypogonadism. This study sought to evaluate the influence of TRT in men with late-onset hypogonadism (LOH), regarding fatigue, coronary artery disease (CAD), carotid intima-media thickness (CIMT) an...

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida Ferreira, Maurício, Mendonça, José Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823386/
https://www.ncbi.nlm.nih.gov/pubmed/35211178
http://dx.doi.org/10.7573/dic.2021-8-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823386/
https://www.ncbi.nlm.nih.gov/pubmed/35211178
http://dx.doi.org/10.7573/dic.2021-8-12

Ejemplares similares